Carter's

CRI · NYSE

$33.65+$0.90 (+2.75%)TodayMarket closed · Oct 20, 6:30 PM ET

Prev close $32.75

CRI analyst rating

HoldConsensus of 7 analysts over the last 12 months. 29% rate it a buy.

Strong buy0
Buy2
Hold3
Underperform1
Sell1

12-month price target · 8 analysts

Average $43.13 (+28.2% upside)

Low: $30.30
Now: $33.65
High: $55.65

Upgrades and downgrades

The latest rating actions, newest first

CRI analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
UBS	Oct 19, 2026	Maintains	Neutral	$41.00 → $38.00	50%
Wells Fargo	Oct 12, 2026	Maintains	Equal-Weight	$42.00 → $30.00	54%
BMO Capital	Sep 9, 2026	Initiates	Outperform	$40.00	74%
Wells Fargo	Jun 17, 2026	Upgrade	Underweight → Equal-Weight	$30.00 → $42.00	54%
UBS	May 11, 2026	Maintains	Neutral	$40.00 → $41.00	50%
Wells Fargo	Apr 29, 2026	Maintains	Underweight	$28.00 → $33.00	54%
Needham	Mar 26, 2026	Initiates	Hold	—	46%
UBS	Feb 19, 2026	Maintains	Neutral	$33.00 → $40.00	50%
Citigroup	Jan 21, 2026	Upgrade	Neutral → Buy	$34.00 → $50.00	53%
Goldman Sachs	Jan 13, 2026	Maintains	Sell	$26.00 → $29.00	75%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.